Analyst Ratings for Elevation Oncology (ELEV)

ELEV Rating Summary

  |   Expand Research on ELEV
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/10/2025 H.C. Wainwright Swayampakula Ramakanth Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.38
(0.37)		 -2.63% Details
6/9/2025 TD Cowen Marc Frahm Downgrade Hold
(Buy)		 N/A
(N/A)		 0.32
(0.37)		 15.63% Details